Skip to content
Clinical Trials – home

Uniwersytecki Szpital Kliniczny W Poznaniu

Verified siteinfo

Poland Ul. Augustyna Szamarzewskiego 84, 60-569 Poznan, Poland

  • 88 trials recruiting
  • Plasma cell myeloma · Malignant melanoma · Ovarian cancer
  • Adults and children

About Specializations

Uniwersytecki Szpital Kliniczny W Poznaniu in Poznan, Poland specialises in clinical trials of conditions such as Plasma cell myeloma, Malignant melanoma, Ovarian cancer, Breast cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology and Neoplasms

At Uniwersytecki Szpital Kliniczny W Poznaniu, clinical research is focused on cancer care, with studies centered on melanoma. The trials are designed to help prevent disease return after surgery and to evaluate new ways of delivering treatment for advanced disease.

  • Completely resected Stage IIb/c melanoma
  • Previously untreated metastatic or unresectable melanoma
  • Testing treatment effectiveness and comparing delivery methods for immunotherapy

These studies reflect a strong interest in improving outcomes for people with melanoma, from reducing recurrence risk to exploring more convenient and potentially effective treatment options.

Melanoma Immunotherapy Research

This research program in Poznan examines immunotherapy for melanoma, including both earlier-stage disease after complete surgery and more advanced cases that have not yet been treated. The goal is to assess how well these approaches work and whether alternative administration routes can support patient care.

  • Recurrence prevention after complete resection of Stage IIB/C melanoma
  • Advanced metastatic or unresectable melanoma
  • Evaluating clinical benefit and treatment delivery options

The site’s activity in oncology highlights a focused effort to advance therapies that may improve both disease control and treatment experience for patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Augustyna Szamarzewskiego 8460-569 PoznanPoland
Recruiting now
88 trials
Conditions studied
163
Partner status
Verified site

More sites in PoznanPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

237 clinical trials

Obesity+2

Recruiting

Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S

Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Renal disorder

Recruiting

BI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.

A study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.

Breast cancer

Recruiting

Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BioNTech SE

Uveal melanoma

Recruiting

A Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Darovasertib
  • Sponsor:Ideaya Biosciences Inc.

A Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Summit Therapeutics Inc.

Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:Unicancer

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Cardiac failure

Recruiting

Study of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.

Study of Lutetium-177-DOTA-TATE with octreotide LAR in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET) with high disease burden

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dimeticone
  • Sponsor:Novartis Pharma AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.